Pacific Point Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Pacific Point Advisors's ABBV Position: Q2 2026 in Review
Pacific Point Advisors increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $2.58K and bringing the position to 1,067 shares worth $269K. The position accounts for 0.12% of the portfolio, ranked #111.
Pacific Point Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pacific Point Advisors held 1,067 shares of AbbVie worth $269K as of Q2 2026.
- Pacific Point Advisors bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
- AbbVie made up 0.12% of Pacific Point Advisors's portfolio in Q2 2026, its #111 holding.
- Pacific Point Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pacific Point Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.